###begin article-title 0
###xml 16 22 <span type="species:ncbi:10090">Murine</span>
Limited Role of Murine ATM in Oncogene-Induced Senescence and p53-Dependent Tumor Suppression
###end article-title 0
###begin p 1
Conceived and designed the experiments: AE MM OFC MS. Performed the experiments: AE MM BMP AOM RS MC. Analyzed the data: AE MM OFC MS. Wrote the paper: OFC MS.
###end p 1
###begin p 2
###xml 733 736 733 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 830 833 830 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1043 1046 1043 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 18 23 <span type="species:ncbi:9606">human</span>
###xml 270 276 <span type="species:ncbi:10090">murine</span>
###xml 334 340 <span type="species:ncbi:10090">murine</span>
###xml 502 507 <span type="species:ncbi:9606">human</span>
###xml 512 518 <span type="species:ncbi:10090">murine</span>
###xml 742 746 <span type="species:ncbi:10090">mice</span>
###xml 1268 1272 <span type="species:ncbi:10090">mice</span>
###xml 1345 1351 <span type="species:ncbi:10090">murine</span>
Recent studies in human fibroblasts have provided a new general paradigm of tumor suppression according to which oncogenic signaling produces DNA damage and this, in turn, results in ATM/p53-dependent cellular senescence. Here, we have tested this model in a variety of murine experimental systems. Overexpression of oncogenic Ras in murine fibroblasts efficiently induced senescence but this occurred in the absence of detectable DNA damage signaling, thus suggesting a fundamental difference between human and murine cells. Moreover, lung adenomas initiated by endogenous levels of oncogenic K-Ras presented abundant senescent cells, but undetectable DNA damage signaling. Accordingly, K-Ras-driven adenomas were also senescent in Atm-null mice, and the tumorigenic progression of these lesions was only modestly accelerated by Atm-deficiency. Finally, we have examined chemically-induced fibrosarcomas, which possess a persistently activated DNA damage response and are highly sensitive to the activity of p53. We found that the absence of Atm favored genomic instability in the resulting tumors, but did not affect the persistent DNA damage response and did not impair p53-dependent tumor suppression. All together, we conclude that oncogene-induced senescence in mice may occur in the absence of a detectable DNA damage response. Regarding murine Atm, our data suggest that it plays a minor role in oncogene-induced senescence or in p53-dependent tumor suppression, being its tumor suppressive activity probably limited to the maintenance of genomic stability.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 69 76 69 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 169 172 169 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATM</italic>
###xml 306 309 306 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Frappart1">[1]</xref>
###xml 311 314 311 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Mavrou1">[2]</xref>
###xml 346 349 346 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 390 393 390 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Xu1">[3]</xref>
###xml 394 397 394 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Elson1">[5]</xref>
###xml 561 564 561 564 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bowen1">[6]</xref>
###xml 565 569 565 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Shen1">[13]</xref>
###xml 116 121 <span type="species:ncbi:9606">human</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 176 182 <span type="species:ncbi:9606">humans</span>
###xml 316 320 <span type="species:ncbi:10090">Mice</span>
ATM plays an important role in tumor suppression as indicated by the in vivo consequences of ATM deficiency both in human and mice. In particular, genetic deficiency of ATM in humans is responsible for the ataxia-telangiectasia syndrome characterized by a high susceptibility to both DNA damage and cancer [1], [2]. Mice genetically deficient in Atm present early onset of thymic lymphomas [3]-[5], and enhanced susceptibility to a variety of experimentally induced cancers, such as, mammary tumors, skin tumors, B-cell lymphomas, intestinal tumors, and others [6]-[13].
###end p 4
###begin p 5
###xml 189 193 189 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Harper1">[14]</xref>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-ODriscoll1">[15]</xref>
###xml 397 401 397 401 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Lombard1">[16]</xref>
###xml 721 725 721 725 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bartek1">[17]</xref>
###xml 727 731 727 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Halazonetis1">[18]</xref>
###xml 810 816 810 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 1186 1190 1186 1190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bartkova1">[19]</xref>
###xml 1192 1196 1192 1196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Gorgoulis1">[20]</xref>
###xml 1422 1426 1422 1426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bartkova2">[21]</xref>
###xml 1427 1431 1427 1431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Mallette1">[23]</xref>
###xml 964 969 <span type="species:ncbi:9606">human</span>
###xml 1297 1302 <span type="species:ncbi:9606">human</span>
At a molecular level, ATM is thought to contribute to cancer protection through two main mechanisms. On one hand, ATM acts locally at the sites of double-strand DNA breaks promoting repair [14]; and, on the other hand, ATM activates p53, directly or through its downstream effector kinase CHK2, promoting p53-dependent responses, such as transient cell cycle arrest, senescence or apoptosis [15], [16]. Each of the above-mentioned activities of ATM, namely, DNA repair and p53 activation, could contribute independently to tumor suppression. The activation of p53 by ATM has gained great relevance lately as a general tumor suppressive mechanism after the proposal of a paradigm meant to apply to the majority of cancers [17], [18]. According to this model, oncogenic signaling in emerging tumor cells induces per se sufficient DNA damage to trigger p53-dependent oncogene-induced senescence. This model is based on two main sets of evidences. First, a variety of human tumors (including bladder, lung, breast and colon tumors, as well as melanoma) at their earliest detectable stages present molecular markers indicative of an ongoing DNA damage response, including phosphorylated ATM [19], [20]. Second, inactivation of individual components of the DNA damage response, such as ATM, in cultured human fibroblasts eliminates oncogene-induced senescence and renders these cells permissive to oncogene-driven proliferation [21]-[23].
###end p 5
###begin p 6
###xml 271 275 271 275 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Efeyan1">[24]</xref>
###xml 277 281 277 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Evan1">[25]</xref>
###xml 315 322 315 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 451 455 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-KellySpratt1">[26]</xref>
###xml 518 522 518 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Christophorou1">[27]</xref>
###xml 524 528 524 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Efeyan2">[28]</xref>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Sarkisian1">[29]</xref>
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Swarbrick1">[30]</xref>
###xml 17 23 <span type="species:ncbi:10090">murine</span>
###xml 343 348 <span type="species:ncbi:10090">mouse</span>
###xml 658 664 <span type="species:ncbi:10090">murine</span>
###xml 748 753 <span type="species:ncbi:9606">human</span>
###xml 827 831 <span type="species:ncbi:10090">mice</span>
Previous work on murine models has put forward an alternative model to explain oncogene-induced p53 activation, being its main features that it is independent of DNA damage and that it places Arf as the critical sensor of oncogenic signaling that mediates p53 activation [24], [25]. This model is well supported by in vivo genetic evidence in mouse cancer models. For example, Arf is essential for the upregulation of p53 in pre-malignant skin tumors [26], for p53-mediated tumor suppression in lymphomas and sarcomas [27], [28], and for oncogene-induced senescence during mammary tumorigenesis [29], [30]. Conceivably, this Arf-based model operating during murine tumorigenesis could coexist with an Atm-based model similar to the one proposed in human tumorigenesis. To test this possibility, we have examined genetically in mice the role of Atm in oncogene-induced senescence and p53-dependent tumor suppression. For this, we have used experimental systems that are well suited to study oncogene-induced senescence and p53-dependent tumor suppression. In this regard, it is important to clarify that our experiments are not designed to address the well-established role of Atm in tumor suppression through the maintenance of genomic stability by DNA repair.
###end p 6
###begin title 7
Results
###end title 7
###begin title 8
###xml 52 57 <span type="species:ncbi:10090">mouse</span>
Oncogenic signaling by Ras does not activate Atm in mouse fibroblasts
###end title 8
###begin p 9
###xml 113 117 113 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bartkova2">[21]</xref>
###xml 118 122 118 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Mallette1">[23]</xref>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Guerra1">[31]</xref>
###xml 626 630 626 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Guerra1">[31]</xref>
###xml 750 754 750 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Sarkisian1">[29]</xref>
###xml 921 928 921 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g001">Fig. 1A</xref>
###xml 1350 1357 1346 1353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g001">Fig. 1B</xref>
###xml 34 39 <span type="species:ncbi:9606">human</span>
###xml 140 146 <span type="species:ncbi:10090">murine</span>
###xml 241 246 <span type="species:ncbi:10090">mouse</span>
###xml 1387 1393 <span type="species:ncbi:10090">murine</span>
###xml 1553 1558 <span type="species:ncbi:9606">human</span>
###xml 1563 1569 <span type="species:ncbi:10090">murine</span>
It has been firmly established in human fibroblasts that oncogenic Ras triggers DNA damage and activation of ATM [21]-[23]. To test this in murine fibroblasts, we overexpressed oncogenic H-Ras by retroviral transduction in wild-type primary mouse embryo fibroblasts (MEFs) and we also activated with 4-hydroxy-tamoxifen (OHT) an inducible endogenous allele of oncogenic K-Ras [31]. In the case of overexpressed oncogenic H-Ras, cells were analyzed 6 days post-infection when, as expected, cells had a clear senescent morphology. In the case of endogenous oncogenic K-Ras, cells continued proliferating, as previously reported [31] and in agreement with the concept that oncogenic signaling must reach a certain threshold before triggering senescence [29]. Interestingly, neither endogenous nor ectopic Ras signaling were able to activate a DNA damage response as judged by the levels of phosphorylated Atm, Chk1 or H2AX (Fig. 1A). To exclude the possibility that DNA damage signaling could occur in a small subpopulation of Ras-expressing MEFs, we used a sensitive automated immunofluorescence method that allows quantifying the signal intensity of phosphorylated-H2AX (gammaH2AX) in individual nuclei. Again, senescent cells overexpressing oncogenic H-Ras did not present evidence of an ongoing DNA damage response, not even in a minority of cells (Fig. 1B). These results suggest that murine fibroblasts undergo Ras-triggered oncogene-induced senescence in the absence of detectable DNA damage signaling. This implies a fundamental difference between human and murine fibroblasts with regard to their susceptibility to activate DNA damage signaling secondary to oncogenic signaling by Ras.
###end p 9
###begin title 10
###xml 95 101 <span type="species:ncbi:10090">murine</span>
Lack of evidence for DNA damage signaling and limited role of Atm in Ras-induced senescence in murine fibroblasts.
###end title 10
###begin p 11
###xml 176 179 176 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 311 314 311 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 987 990 983 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
A. Immunoblots illustrating the phosphorylation status of Atm, Chk1 and H2AX under different conditions: infection of early passage primary MEFs with an empty vector or with H-RasV12 expressing retrovirus (analyzed 6 days post-selection when cells were morphologically senescent), activation of an endogenous K-RasV12 allele with 4-hydroxy-tamoxifen (OHT), and finally controls of DNA damage by replicative stress using hydroxyurea (HU 1 mM, 3 hrs) and by DNA breaks using ionizing radiation (IR 3 Gy, 45 min). B. Quantitative immunofluorescence of gammaH2AX in single cells from the same populations analysed in part A using high-throughput microscopy. The average intensity of the population is indicated with a bar. Note that upon replicative stress (HU) only the fraction of cells in S-phase activate the DDR, while upon irradiation (IR) the entire population activates the DDR. C. Immunoblots of the indicated proteins 6 days after selection of cells retrovirally transduced with H-RasV12.
###end p 11
###begin p 12
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 117 121 117 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Wang1">[32]</xref>
###xml 123 127 123 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Ito1">[33]</xref>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 462 469 462 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g001">Fig. 1C</xref>
###xml 482 485 482 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 633 640 633 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s001">Fig. S1</xref>
###xml 795 798 795 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 852 858 <span type="species:ncbi:10090">murine</span>
Atm-null fibroblasts undergo premature senescence due to their high levels of reactive oxygen species and DNA damage [32], [33], thus precluding an analysis of oncogene-induced senescence. Therefore, we restricted our analysis to the ability of oncogenic H-Ras to activate p53 in the absence of Atm. Interestingly, both Arf and p53 levels were increased in Atm-null MEFs upon overexpression of oncogenic H-Ras, in a manner indistinguishable from wild-type MEFs (Fig. 1C). Moreover, Atm-null MEFs were not permissive to H-RasV12-driven proliferation, either alone or in combination with the cooperating oncoprotein E1a (Supplementary Fig. S1). Although, as mentioned above, the lack of permissiveness to oncogene-driven proliferation could be due in part to the intrinsic premature senescence of Atm-null MEFs. Together, these results indicate that, in murine fibroblasts, oncogenic Ras signaling activates p53 independently of Atm.
###end p 12
###begin title 13
Atm is not necessary for senescence in K-RasV12-driven lung adenomas
###end title 13
###begin p 14
###xml 53 56 53 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 116 120 116 120 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Meuwissen1">[34]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Johnson1">[35]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Jackson1">[36]</xref>
###xml 338 342 338 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Collado1">[37]</xref>
###xml 402 409 402 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 431 434 431 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 489 493 489 493 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bartkova1">[19]</xref>
###xml 495 499 495 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Gorgoulis1">[20]</xref>
###xml 555 559 555 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bartkova2">[21]</xref>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-DiMicco1">[22]</xref>
###xml 650 653 650 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Guerra1">[31]</xref>
###xml 883 886 883 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 966 969 966 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 987 990 987 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1033 1036 1033 1036 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 90 95 <span type="species:ncbi:9606">human</span>
###xml 589 593 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 890 894 <span type="species:ncbi:10090">mice</span>
###xml 1003 1007 <span type="species:ncbi:10090">mice</span>
Lung tumorigenesis induced by endogenous oncogenic K-Ras alleles faithfully recapitulates human lung adenocarcinoma [34], and presents two characteristics of relevance for this study, namely, tumorigenesis is suppressed by p53 [35], [36] and it is accompanied by a readily detectable senescence response at the pre-malignant tumor stages [37]. Therefore, this is a well-suited cancer model to evaluate in vivo the proposed role of Atm as a general barrier to cancer, including lung cancer [19], [20], through the activation of oncogene-induced senescence [21], [22]. Specifically, we used mice carrying the above-mentioned OHT-inducible endogenous K-RasV12 allele [31]. The oncogenic allele is linked to a LacZ reporter that allows detection of those cells in which the oncogene has been activated by Cre-mediated excision upon OHT. For simplicity, we will refer to these mice as "K-RasV12 mice". In the following paragraphs, we describe separately the phenotype of Atm-heterozygous and Atm-nullizygous mice when combined with the K-RasV12 allele activated by OHT at 1 month of age.
###end p 14
###begin p 15
###xml 10 13 10 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 80 83 80 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Xu1">[3]</xref>
###xml 84 87 84 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Elson1">[5]</xref>
###xml 142 145 142 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 204 211 204 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g002">Fig. 2A</xref>
###xml 238 241 238 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 298 301 298 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 442 445 442 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 448 452 448 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">/Atm</italic>
###xml 504 511 504 511 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s002">Fig. S2</xref>
###xml 727 730 724 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 867 874 852 859 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s002">Fig. S2</xref>
###xml 1103 1106 1088 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 19 23 <span type="species:ncbi:10090">mice</span>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
Regarding Atm-null mice, these mice succumb to thymic lymphomas at an early age [3]-[5] and we observed that the presence or absence of the K-RasV12 allele did not affect survival in an Atm-null context (Fig. 2A). Examination of moribund Atm-null mice indicated that all of them, with or without K-RasV12, developed thymic lymphomas with similar histopathological characteristics (not shown). All the thymic lymphomas (n = 5) examined from K-RasV12/Atm-null animals were positive for LacZ (Supplementary Fig. S2; note that this staining is at pH 7 and does not produce cross-staining with senescence-associated beta-galactosidase, which is measured at pH 6). The above is an interesting observation because expression of the K-RasV12 oncogene was achieved in approximately8% of the cells of the thymus (quantified in scanned photographs; see example in Supplementary Fig. S2). These observations suggest that those thymocytes carrying the activated oncogene have a selective advantage compared to the non-oncogenic ones. We conclude that K-RasV12 has a modest impact on thymic lymphomagenesis driven by Atm-loss, providing a selective advantage to the tumoral cells, but without accelerating tumor onset.
###end p 15
###begin title 16
###xml 34 40 <span type="species:ncbi:10090">murine</span>
Limited role of Atm in Ras-driven murine lung tumorigenesis.
###end title 16
###begin p 17
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 246 249 246 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 266 269 266 269 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 431 432 431 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 146 150 <span type="species:ncbi:10090">mice</span>
###xml 282 286 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
A. Kaplan-Meier survival curves of the indicated mice (n = 15 mice for each group). The inducible K-RasV12 allele was activated with OHT when the mice were 1 month old. B. Quantification of the different grades of lesions found in the lungs of K-RasV12/Atm-wt and K-RasV12/Atm-null mice (15 mice per group, and a total of n = 121 and n = 108 lesions, respectively). Asterisks indicate statistical significance of the Fisher's test p<0.05.
###end p 17
###begin p 18
###xml 35 39 35 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Guerra1">[31]</xref>
###xml 195 198 195 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 263 266 263 266 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 308 311 308 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 328 335 328 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g002">Fig. 2A</xref>
###xml 350 351 350 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 86 90 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 322 326 <span type="species:ncbi:10090">mice</span>
In agreement with previous results [31], oncogenic activation of K-Ras in 1-month old mice led to lung carcinogenesis with full penetrance and death between 9 and 16 months of age. Unexpectedly, Atm-heterozygosity did not diminish significantly the survival of K-RasV12 mice when compared with their control Atm wild-type mice (Fig. 2A; logrank test p = 0.79) and histopathological analyses confirmed that death was due to the presence of multiple lung tumors.
###end p 18
###begin p 19
###xml 41 44 41 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 193 196 193 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 222 225 222 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 235 238 235 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 272 275 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 352 355 352 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 577 582 577 582 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et al</italic>
###xml 584 588 584 588 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Johnson1">[35]</xref>
###xml 659 662 659 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 709 712 709 712 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 736 739 736 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 881 884 881 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 962 969 962 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g002">Fig. 2B</xref>
###xml 1125 1128 1101 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1314 1321 1290 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g002">Fig. 2B</xref>
###xml 58 62 <span type="species:ncbi:10090">mice</span>
###xml 164 168 <span type="species:ncbi:10090">mice</span>
###xml 242 246 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 729 734 <span type="species:ncbi:10090">mouse</span>
###xml 758 763 <span type="species:ncbi:10090">mouse</span>
###xml 1134 1138 <span type="species:ncbi:10090">mice</span>
Despite the previous negative data using Atm-heterozygous mice, we reasoned that the role of Atm in K-RasV12-driven lung tumorigenesis could perhaps be revealed in mice completely deficient in Atm. For this, we sacrificed Atm-null and Atm-wt mice carrying the activated K-RasV12 allele at 5 months of age (4 months post-activation with OHT), when most Atm-null mice had not developed yet frank lymphomas but lung tumors were already present. Tumors were counted and grouped in 4 grades, from adenomas (G1-G3) to adenocarcinomas (G4), according to the classification of Johnson et al. [35]. Quantification of the number of lesions indicated that the status of Atm had no significant impact on tumor incidence (Atm-wt: 8.1 lesions/mouse; Atm-null: 7.2 lesions/mouse; n = 15 per genotype). Interestingly, histopathological analysis of more than 100 lesions per genotype revealed that Atm-nullizygosity had a modest, albeit significant, effect on tumor progression (Fig. 2B). This effect was restricted to the pre-malignant stages with a approximately50% decrease in G1 adenomas and a approximately50% increase in G3 adenomas in Atm-null mice compared to their wt controls. At this time of analysis (5 months of age), no significant differences were observed in the incidence of malignant tumors (G4, adenocarcinoma) (Fig. 2B).
###end p 19
###begin p 20
###xml 56 59 56 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 110 113 110 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 188 192 188 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Collado1">[37]</xref>
###xml 302 306 296 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Dimri1">[38]</xref>
###xml 321 324 315 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 385 388 379 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 402 409 396 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g003">Fig. 3A</xref>
###xml 460 467 454 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s003">Fig. S3</xref>
###xml 493 497 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Collado1">[37]</xref>
###xml 573 580 564 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s003">Fig. S3</xref>
###xml 593 596 584 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 647 650 638 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 664 671 655 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g003">Fig. 3B</xref>
###xml 695 698 686 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1032 1039 1019 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g003">Fig. 3C</xref>
###xml 1180 1187 1167 1174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g003">Fig. 3D</xref>
###xml 119 123 <span type="species:ncbi:10090">mice</span>
Next, we wondered whether, despite the modest effect of Atm-deficiency on tumor progression, lung adenomas in Atm-null mice had lost the senescence response characteristic of these tumors [37]. Senescence was evaluated by the widely accepted marker senescence-associated beta-galactosidase (SAbetaGal; [38]). Remarkably, Atm-null adenomas presented a senescence response comparable to Atm-wt adenomas (Fig. 3A; for whole lung panoramic views see Supplementary Fig. S3). As previously reported [37], adenocarcinomas were negative for SAbetaGal (see example in Supplementary Fig. S3). Moreover, Atm-null adenomas had the same proliferative index as Atm-wt adenomas (Fig. 3B), thus indicating that Atm is not a barrier for the proliferation of these pre-malignant lesions (apoptosis was essentially undetectable in these lesions, not shown). These negative data prompted us to evaluate whether the K-RasV12-driven adenomas had an ongoing DNA damage response, however, we were unable to detect gammaH2AX positive cells in the adenomas (Fig. 3C). Finally, as an additional control, induction of the senescence mediator Arf was readily detected in lung adenomas, but not in carcinomas (Fig. 3D), further reinforcing the idea that oncogene-induced senescence in this model occurs in the absence of DNA damage signaling.
###end p 20
###begin title 21
###xml 79 85 <span type="species:ncbi:10090">murine</span>
Lack of evidence for DNA damage signaling and limited role of Atm in senescent murine lung tumors.
###end title 21
###begin p 22
###xml 112 115 106 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 132 135 126 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 220 227 214 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s003">Fig. S3</xref>
###xml 555 558 542 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 728 731 715 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 381 386 <span type="species:ncbi:10090">mouse</span>
###xml 668 673 <span type="species:ncbi:10090">mouse</span>
A. Representative stainings of senescence-associated beta-galactosidase (SAbetaGal) in lung cryosections from K-RasV12/Atm-wt and K-RasV12/Atm-null mice. The grade of the tumor (G2 or G3) is indicated. See Supplementary Fig. S3 for panoramic views, including adenocarcinomas (G4, which are negative for SAbetaGal). B. Examples of Ki67 stainings of lung adenomas from the indicated mouse genotypes and quantification (adenomas n = 4 for each genotype). Values correspond to the average and standard deviation. C. Lack of detectable gammaH2AX staining in K-RasV12-driven lung adenomas. The bottom panel shows a positive control of the lung from an irradiated wildt-type mouse (5 Gy, 45 min post-IR). D. Expression of Arf during K-RasV12-driven lung tumorigenesis is specifically associated to the pre-malignant stages (adenomas, top), but not to the malignant ones (adenocarcinomas, bottom). Note that some cells in the adenoma are Arf-positive and others are Arf-negative, consistent with the concept that not all the tumor cells of these lesions are senescent, and indeed a fraction of cells are proliferating, as shown in part B.
###end p 22
###begin p 23
###xml 221 224 221 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 254 257 254 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
Collectively, we conclude from the above data that senescence at the pre-malignant stages of K-RasV12-driven lung tumorigenesis is not associated to a detectable DNA damage response and it is independent of the status of Atm. Accordingly, the absence of Atm has a modest impact on the pre-malignant stages of this tumorigenesis model. It is conceivable that loss of function of Atm could increase aggressiveness at later stages of tumorigenesis.
###end p 23
###begin title 24
Limited role of Atm in protection from chemically-induced fibrosarcomas
###end title 24
###begin p 25
###xml 364 367 364 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 373 376 373 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Efeyan2">[28]</xref>
###xml 382 386 382 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Eva1">[39]</xref>
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Watanabe1">[41]</xref>
###xml 427 430 427 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 474 478 474 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Watanabe1">[41]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Shimokado1">[42]</xref>
###xml 722 725 722 725 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 732 735 732 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 766 769 766 769 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 810 813 810 813 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 925 929 925 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-GarciaCao1">[43]</xref>
###xml 967 974 967 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1064 1067 1064 1067 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1075 1078 1075 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1091 1094 1091 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1271 1274 1271 1274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1294 1297 1294 1297 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1333 1336 1333 1336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1396 1399 1396 1399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1425 1432 1425 1432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s004">Fig. S4</xref>
###xml 1472 1475 1472 1475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1537 1540 1537 1540 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1561 1564 1561 1564 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 1580 1587 1580 1587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g004">Fig. 4A</xref>
###xml 1854 1858 1854 1858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Efeyan2">[28]</xref>
###xml 1869 1876 1869 1876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g004">Fig. 4A</xref>
###xml 2221 2228 2193 2200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g004">Fig. 4B</xref>
###xml 2329 2332 2301 2304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 2334 2341 2306 2313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g004">Fig. 4B</xref>
###xml 2388 2391 2356 2359 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 2551 2554 2519 2522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 2571 2574 2539 2542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 2675 2682 2639 2646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g004">Fig. 4B</xref>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
###xml 676 680 <span type="species:ncbi:10090">mice</span>
###xml 804 808 <span type="species:ncbi:10090">mice</span>
###xml 2560 2564 <span type="species:ncbi:10090">mice</span>
###xml 2581 2585 <span type="species:ncbi:10090">mice</span>
To further evaluate the role of Atm in a cancer model initiated by DNA damage and under a strong control by p53-mediated tumor suppression, we performed chemical carcinogenesis with the DNA damaging agent 3-methyl-cholanthrene (3MC). This carcinogen generates fibrosarcomas when injected intramuscularly in mice, and tumors carry frequent oncogenic mutations in K-Ras or N-Ras[28], [39]-[41], together with a high incidence of p53 inactivation by deletion or point mutation [41], [42]. Confirming the relevant role of p53 in the control of these tumors, we have previously shown that the latency of 3MC-fibrosarcomas is highly sensitive to the activity of p53. In particular, mice carrying three functional alleles of the p53 gene (p53-super) have a 50% increase in p53 gene dosage relative to wild-type mice (p53-wt), and this increase in p53 activity translates into a significant delay in the latency of 3MC-fibrosarcomas [43]. To evaluate the role of Atm in this in vivo assay of p53-mediated tumor suppression, we performed the appropriate crosses to compare p53-wt and p53-super in an Atm-null background. As validation of our genetic system, we observed that the short-term response of p53 to acute DNA damage (3h post-irradiation) was abrogated in the absence of Atm, regardless of the p53 gene dose; and, in the presence of Atm, the levels of p53 and p21 were directly associated to the p53 gene dose (Supplementary Fig. S4). However, unexpectedly, the status of Atm did not affect the latency of 3MC-fibrosarcomas neither in a p53-wt context nor in a p53-super context (Fig. 4A; statistical analyses indicated in the legend). The lack of effect of Atm is in contrast to the dramatic effect of Arf, whose deficiency completely abrogates p53-mediated tumor suppression in this cancer model without affecting the short-term response to DNA damage [28] (see also Fig. 4A). Tumors from all the genotypes (n = 5 per genotype) were characterized histologically and all of them showed a strong constitutive DNA damage response (approximately50% of cells positive for gammaH2AX), a high mitotic index (approximately50% of cells positive for Ki67), and very low apoptosis (<1% of cells positive for activated caspase-3) (Fig. 4B). Quantification of these markers indicated that their prevalence was not affected by the status of Atm (Fig. 4B). The presence of high levels of gammaH2AX in Atm-null tumors indicates that other kinases from the Atm family are responsible for the phosphorylation of H2AX, such as Atr or Dnapk. Of note, tumors arising in Arf-null mice or in p53-super mice showed a modest, albeit significant, decrease in the number of gammaH2AX-positive cells (Fig. 4B).
###end p 25
###begin title 26
Limited role of Atm in p53-mediated tumor suppression and DNA damage response in chemically-induced fibrosarcomas.
###end title 26
###begin p 27
###xml 49 52 49 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 87 90 87 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 97 100 97 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 119 122 119 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 362 365 362 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 373 374 373 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 383 386 383 386 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 406 409 406 409 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 416 417 416 417 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 429 432 429 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 446 447 446 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 506 509 506 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 516 517 516 517 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 530 533 530 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 544 547 544 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 554 557 554 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 564 565 564 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 3 7 <span type="species:ncbi:10090">Mice</span>
###xml 736 740 <span type="species:ncbi:10090">mice</span>
###xml 836 840 <span type="species:ncbi:10090">mice</span>
A. Mice of the indicated genotypes, wt (n = 15), p53-super (n = 16), Atm-null (n = 9), p53-super/Atm-null (n = 13) and Arf-null (n = 12), were injected intramuscularly with 3-methyl-cholanthrene (3MC) and tumour development was monitored. Kaplan-Meier tumour-free curves were obtained and statistical significant differences (logrank test) were found for wt vs. p53-super (p<0.005), Atm-null vs. p53-super/Atm-null (p<0.001) and Arf-null vs. wt (p<0.0001). No significant differences were found for wt vs. Atm-null (p = 0.11), or p53-super vs. p53-super/Atm-null (p = 0.18). B. Quantification of the persistent DNA damage response (gammaH2AX), proliferation (Ki67), and apoptosis (activated caspase-3) in 3MC-fibrosarcomas generated in mice of the indicated genotypes. Quantifications are relative to the 3MC-fibrosarcomas in wild-type mice. Values correspond to the average and standard deviation (n = 5 per genotype). Examples of the immunostainings are shown in the panels at the right.
###end p 27
###begin p 28
###xml 20 23 20 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 493 496 493 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 535 538 535 538 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 546 549 546 549 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 627 631 627 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 670 677 670 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005475-t001">Table 1</xref>
###xml 694 701 694 701 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g005">Fig. 5A</xref>
###xml 864 867 864 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 976 979 976 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 995 1002 995 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005475-t001">Table 1</xref>
###xml 1007 1014 1007 1014 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g005">Fig. 5A</xref>
###xml 1077 1081 1077 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Efeyan3">[44]</xref>
###xml 1103 1106 1103 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 1164 1168 1164 1168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 1206 1213 1206 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005475-t001">Table 1</xref>
###xml 1215 1222 1215 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g005">Fig. 5A</xref>
###xml 1245 1252 1245 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s005">Fig. S5</xref>
###xml 1307 1310 1307 1310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 1338 1341 1338 1341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1401 1404 1401 1404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 1112 1116 <span type="species:ncbi:10090">mice</span>
We wondered whether Atm-nullizygosity, despite its lack of effect on tumor latency, could relieve the selective pressure to inactivate p53. For this, we examined the functional status of p53 in 3MC-fibrosarcomas and in cell lines derived from these tumors. Inactivation of p53 by point mutation generally renders p53 abnormally stable and readily detectable by immunohistochemistry, and results in undetectable levels of the p53-target p21. The large majority of 3MC-fibrosarcomas produced in Atm-wt mice (19/22 = 86%, after combining p53-wt and p53-super) had an immunohistochemical profile consistent a "p53 mutant" pattern (i.e. p53-strongly positive & p21-negative; Table 1, see example in Fig. 5A), thus confirming the strong pressure to inactivate p53 in this cancer model. Importantly, a similar situation was observed in the 3MC-fibrosarcomas generated in Atm-null mice, where the majority (14/18 = 78%) also had a "p53-mutant" pattern, including those generated in a p53-super context (Table 1 and Fig. 5A). In contrast to this and in agreement with our previous data [44], tumors generated in Arf-null mice presented a "p53 functional" staining pattern (i.e. p53-weakly positive & p21- positive; Table 1, Fig. 5A and see Supplementary Fig. S5 for a nutlin-sensitivity assay), thus confirming that Arf-deficiency, in contrast to Atm-deficiency, completely relieves the pressure to inactivate p53.
###end p 28
###begin title 29
Absence of Atm does not relieve the selective pressure to inactivate p53 during chemical carcinogenesis.
###end title 29
###begin p 30
###xml 91 98 91 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005475-t001">Table 1</xref>
###xml 220 223 220 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 284 288 284 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 404 407 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i.e.</italic>
###xml 817 827 817 827 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s005">Figures S5</xref>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s006">S6</xref>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 413 417 <span type="species:ncbi:10090">mice</span>
###xml 662 666 <span type="species:ncbi:10090">mice</span>
A. Representative images of 3MC-fibrosarcomas immunostained for Arf, p53 and p21 (see also Table 1). The upper and middle rows are representative of the large majority of fibrosarcomas developed in wild-type (upper) and Atm-null (middle) mice, which are consistent with a mutant p53 (i.e. strongly positive for p53 and negative for p21). The lower row is representative of the fibrosarcomas developed in Arf-null mice, which are consistent with a functional p53 (i.e. very weakly positive for p53 and positive for p21). B. Examples of cancer cell lines established from 3MC-fibrosarcomas (each line derives from an independent fibrosarcoma). The genotype of the mice where the 3MC-fibrosarcomas were generated is indicated, as well as, the status of p53 as determined by a nutlin-sensitivity assay (see Supplementary Figures S5 and S6). Cell lines were exposed to 10 Gy and protein extracts were obtained 1h and 24h after irradiation. The levels of the indicated proteins were determined by immunoblotting using beta-actin as loading control.
###end p 30
###begin title 31
Immunohistochemical analysis of 3MC-fibrosarcomas.
###end title 31
###begin p 32
Most tumors strongly positive for p53, lacked p21 expression (reflecting a non-functional mutant p53); and, tumors negative or weakly positive for p53, had detectable p21 (reflecting a functional p53)
###end p 32
###begin p 33
The few tumors that lacked Arf were negative or weakly positive for p53 (reflecting a functional p53)
###end p 33
###begin p 34
###xml 127 130 127 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 264 271 264 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g005">Fig. 5B</xref>
###xml 439 446 439 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g005">Fig. 5B</xref>
###xml 664 667 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 813 816 813 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 912 915 912 915 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 965 972 965 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g005">Fig. 5B</xref>
###xml 1046 1049 1046 1049 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1061 1064 1061 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 380 384 <span type="species:ncbi:10090">mice</span>
###xml 566 570 <span type="species:ncbi:10090">mice</span>
###xml 673 677 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 921 925 <span type="species:ncbi:10090">mice</span>
###xml 1055 1059 <span type="species:ncbi:10090">mice</span>
To further substantiate the above observations, we examined the functionality of p53. The cancer cell lines derived from wt or Atm-null mice had constitutively high levels of p53 and essentially undetectable levels of p21 both before and after ionizing radiation (Fig. 5B, lanes 1-10), compatible with a mutant p53 status. We wondered whether the 3MC-fibrosarcomas produced in wt mice retained a normal response to DNA damage. As shown in Fig. 5B, the phosphorylation of Chk2, Atm and H2AX shortly after ionizing radiation was normal in representative lines from wt mice (lanes 1,2,7-10) but, as expected, Chk2 phosphorylation was absent in the fibrosarcomas from Atm-null mice (lanes 3-6). Therefore, 3MC-fibrosarcomas derived from wild-type mice retain an apparently functional Atm and DNA damage response, and Atm-deficiency does not relieve the pressure to inactivate p53. The cancer cell lines derived from Arf-null mice also had a normal DNA damage response (Fig. 5B, lanes 11-14), but in sharp contrast with those fibrosarcomas from wt or Atm-null mice, Arf-null fibrosarcomas conserved a functional p53/p21 response to DNA damage (lanes 11-14).
###end p 34
###begin p 35
###xml 43 46 43 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 341 348 341 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005475-t002">Table 2</xref>
###xml 428 431 428 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 625 632 625 632 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s006">Fig. S6</xref>
###xml 816 820 816 820 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf-</italic>
###xml 847 854 847 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005475-t002">Table 2</xref>
###xml 917 920 917 920 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
Finally, to seek evidence for an impact of Atm-deficiency in this cancer model, we examined the level of genomic instability in the different 3MC-fibrosarcoma cell lines described above. Consistent with the well-established role of p53 in genomic stability, those fibrosarcomas lacking functional p53 had high levels of chromosomal fusions (Table 2). To dissociate the impact of p53 and Atm on genomic stability, we grouped the Atm-null cancer cell lines into those with mutant p53 and those with functional p53 (treatment with the MDM2 inhibitor nutlin confirmed the presence or absence of functional p53, see Supplementary Fig. S6). Interestingly, cancer cells deficient in Atm, but not in p53, had significantly higher levels of chromosomal instability, particularly fusions and aneuploidies, than the comparable Arf-null;p53-functional cells (Table 2). In summary, these observations indicate that the absence of Atm increases genomic instability, but it does not relieve the pressure to inactivate p53 during cancer development.
###end p 35
###begin title 36
Chromosomal instability in 3MC-fibrosarcoma cell lines.
###end title 36
###begin p 37
###xml 158 165 154 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g005">Fig. 5A</xref>
###xml 187 194 183 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g005">Fig. 5B</xref>
###xml 296 303 292 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s005">Fig. S5</xref>
###xml 308 310 304 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s006">S6</xref>
The functional status of p53 in the fibrosarcoma cell lines was determined by examining the levels of p53 and p21 upon gammaIR, both by immunohistochemistry (Fig. 5A) and immunoblotting (Fig. 5B), as well as, by their susceptibility to cell cycle arrest upon treatment with nutlin (Supplementary Fig. S5 and S6).
###end p 37
###begin p 38
###xml 6 9 6 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 103 106 103 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 154 161 154 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005475-t001">Table 1</xref>
###xml 166 173 166 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g005">Fig. 5B</xref>
###xml 249 256 249 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s006">Fig. S6</xref>
###xml 279 282 279 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 288 291 288 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 330 333 330 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 339 342 339 342 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 298 303 <span type="species:ncbi:10090">mouse</span>
###xml 346 351 <span type="species:ncbi:10090">mouse</span>
These Atm-null lines with functional p53 correspond to a minority of the 3MC-fibrosarcomas produced in Atm-null mice, which by large have mutant p53 (see Table 1 and Fig. 5B). Only two lines were obtained that retained functional p53 (Supplementary Fig. S6): one derived from an Atm-null;p53-super mouse and the other one from an Atm-null;p53-wt mouse.
###end p 38
###begin p 39
Aneuploidies correspond to metaphasases with chromosome numbers different from 40+/-1 or 80+/-2.
###end p 39
###begin p 40
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 120 121 120 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 152 153 152 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Statistical comparison (t-test) between Atm-null(p53-functional) and Arf-null(p53-functional): metaphases with fusions, p = 0.04; aneuploid cell lines, p = 0.06.
###end p 40
###begin p 41
###xml 95 98 95 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
Collectively, we conclude that Atm plays a minor role in 3MC carcinogenesis. In the absence of Atm, genomic instability is favored, yet neither the DNA damage response nor p53-mediated tumor suppression are affected.
###end p 41
###begin title 42
Discussion
###end title 42
###begin p 43
###xml 400 404 400 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bartek1">[17]</xref>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Halazonetis1">[18]</xref>
###xml 534 538 534 538 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bartkova2">[21]</xref>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Mallette1">[23]</xref>
###xml 585 592 585 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 442 447 <span type="species:ncbi:9606">human</span>
###xml 709 715 <span type="species:ncbi:10090">murine</span>
###xml 772 777 <span type="species:ncbi:10090">mouse</span>
The role of ATM in tumor suppression is solidly established and attributed, at least in part, to its well-known function in DNA damage repair. In addition to its function in guarding the genome, ATM has been recently proposed to act as a general tumor suppressor through its ability to activate p53 in response to oncogenic stress and the subsequent induction of oncogene-induced cellular senescence [17], [18]. This model is mainly based on human cultured fibroblasts where ATM plays an essential role in oncogene-induced senescence [21]-[23]. In this work, we have attempted to find in vivo supporting evidence for the role of ATM in p53-dependent tumor suppression and in oncogene-induced senescence using murine experimental systems, namely, Ras-induced senescence in mouse embryo fibroblasts (MEFs), Ras-induced senescence during lung tumorigenesis, and chemically-induced fibrosarcomas.
###end p 43
###begin p 44
###xml 608 611 608 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 771 775 771 775 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Collado1">[37]</xref>
###xml 881 884 881 884 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 949 953 949 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Collado1">[37]</xref>
###xml 955 962 955 962 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g003">Fig. 3C</xref>
###xml 989 992 989 992 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1126 1129 1126 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1252 1255 1252 1255 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 1318 1321 1318 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 1325 1329 1325 1329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Dovey1">[45]</xref>
###xml 1411 1415 1411 1415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Sarkisian1">[29]</xref>
###xml 1417 1421 1417 1421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Swarbrick1">[30]</xref>
###xml 1492 1498 <span type="species:ncbi:10090">murine</span>
A first unexpected observation was the absence of a detectable DNA damage response upon ectopic overexpression of oncogenic H-Ras in MEFs, under conditions that resulted in upregulation of Arf, stabilization of p53, and acquisition of a fully senescent morphology. Given the absence of a detectable DNA damage response elicited by oncogenic H-Ras, it was not surprising that the stabilization of p53 in response to the oncogene was not affected by the absence of Atm. Conceptually similar observations were made in a more physiological model of oncogene-induced senescence in which an inducible endogenous K-RasV12 allele drives the development of adenomas (pre-malignant) and adenocarcinomas (malignant), being characterized the adenomas by a strong senescence response [37]. Again, as in the case of MEFs, we could not detect evidence of persistent DNA damage signaling in the K-RasV12-driven adenomas, which were invariably senescent as shown in [37] (Fig. 3C). Consistently with this, Atm deficiency did not ablate the senescent response characteristically present in lung adenomas. Interestingly, however, the absence of Atm had a modest, albeit significant, effect in the degree of progression of adenomas. In contrast to these data, ablation of Arf strongly accelerates lung tumorigenesis driven by oncogenic K-RasV12 [45], and it eliminates oncogenic Ras-induced senescence during mammary tumorigenesis [29], [30]. Together, these results indicate that oncogene-induced senescence in murine fibroblasts and lung epithelial cells is not associated to an ongoing DNA damage response and, therefore, activation of p53 and establishment of senescence occur independently of Atm.
###end p 44
###begin p 45
###xml 177 181 177 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-GarciaCao1">[43]</xref>
###xml 240 247 240 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g004">Fig. 4B</xref>
###xml 274 277 274 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 480 483 480 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 986 990 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Liao1">[46]</xref>
###xml 992 996 992 996 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bailey1">[47]</xref>
###xml 1293 1297 1293 1297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-KellySpratt1">[26]</xref>
###xml 1298 1302 1298 1302 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Efeyan2">[28]</xref>
###xml 1304 1308 1304 1308 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Eischen1">[48]</xref>
###xml 1310 1314 1310 1314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Schmitt1">[49]</xref>
###xml 1362 1365 1362 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 1555 1562 1555 1562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g005">Fig. 5B</xref>
###xml 1686 1689 1686 1689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1829 1832 1829 1832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 1914 1921 1914 1921 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005475-t002">Table 2</xref>
###xml 41 47 <span type="species:ncbi:10090">murine</span>
###xml 956 962 <span type="species:ncbi:10090">murine</span>
###xml 1371 1375 <span type="species:ncbi:10090">mice</span>
Based on the above data, we focused on a murine cancer model initiated by a DNA damage agent (3-methyl-cholanthrene or 3MC), known to be highly sensitive to the activity of p53 [43], and accompanied by a persistent DNA damage response (see Fig. 4B). However, the absence of Atm did not impact on the kinetics of tumor development, even under conditions able to detect a 1.5-fold difference in p53 activity. Histopathological analyses of these tumors indicated that the absence of Atm did not decrease the persistent DNA damage response, which must be signaled by other kinases of the Atm family, such as Atr or Dnapk. Importantly, the absence of Atm did not relieve the strong selective pressure to inactivate p53, further confirming that the tumor suppressor activity of p53 in this cancer model is not regulated by Atm. These results are in agreement with previous reports that also failed to detect an impact of Atm on p53-mediated tumor suppression in murine brain and skin cancers [46], [47]. The absence of effect of Atm on p53-dependent tumor suppression is in sharp contrast with a number of reports where the absence of Arf essentially eliminates p53-mediated tumor suppression and completely alleviates the selective pressure to inactivate p53 in lymphomas, sarcomas and skin tumors [26]-[28], [48], [49]. Moreover, the 3MC-fibrosarcomas originated in Arf-null mice retained a functional response to DNA damage, as judged by the phosphorylation of Atm and H2AX, as well as, by the stabilization of p53 and the induction of p21 upon irradiation (Fig. 5B). In summary, in this cancer model initiated by a DNA damage agent and associated to persistent DNA damage, the absence of Atm does not have a detectable effect on DNA damage signaling or on p53-dependent tumor suppression. Finally, and interestingly, we found that Atm-null fibrosarcomas were characterized by high levels of chromosomal instability (Table 2), thus testifying to the known role of Atm in genome stability.
###end p 45
###begin p 46
###xml 158 170 158 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s1">Introduction</xref>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Bartek1">[17]</xref>
###xml 328 332 328 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Halazonetis1">[18]</xref>
###xml 398 406 398 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 138 143 <span type="species:ncbi:9606">human</span>
###xml 148 152 <span type="species:ncbi:10090">mice</span>
###xml 380 385 <span type="species:ncbi:9606">human</span>
###xml 450 456 <span type="species:ncbi:10090">murine</span>
###xml 700 705 <span type="species:ncbi:9606">human</span>
###xml 710 716 <span type="species:ncbi:10090">murine</span>
###xml 872 877 <span type="species:ncbi:9606">human</span>
###xml 897 903 <span type="species:ncbi:10090">murine</span>
It is critically important to emphasize that our data do not negate a tumor suppressor role for ATM, which is solidly established both in human and mice (see Introduction), but question the generality of the model proposed for ATM as a critical mediator of p53-activation and senescence in response to oncogenic signaling [17], [18]. This model is mainly based on the behavior of human fibroblasts in vitro and it does not seem to apply to the three murine experimental systems analyzed here, namely, oncogene-induced senescence in fibroblasts and during lung tumorigenesis, and p53-mediated tumor suppression during carcinogenesis initiated by a DNA damage agent. By large, the molecular biology of human and murine cancer seem to follow the same mechanistic paradigms, however, it is conceivable that ATM is an exceptional case playing a major tumor suppression role in human cancer, but not in murine cancer.
###end p 46
###begin title 47
Materials and Methods
###end title 47
###begin title 48
Ethics statement
###end title 48
###begin p 49
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were treated in accordance with the Spanish Laws and the Guidelines for Humane Endpoints for Animals Used in Biomedical Research.
###end p 49
###begin title 50
###xml 10 14 <span type="species:ncbi:10090">mice</span>
Cells and mice
###end title 50
###begin p 51
###xml 2 5 2 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 9 12 9 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 122 125 122 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Guerra1">[31]</xref>
###xml 158 161 158 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 172 175 172 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Barlow1">[4]</xref>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 302 306 302 306 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Guerra1">[31]</xref>
###xml 308 311 308 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Arf</italic>
###xml 322 326 322 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Kamijo1">[50]</xref>
###xml 331 334 331 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p53</italic>
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Jacks1">[51]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Pantoja1">[52]</xref>
###xml 872 875 872 875 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Atm</italic>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 49 64 <span type="species:ncbi:10090">transgenic mice</span>
###xml 167 171 <span type="species:ncbi:10090">mice</span>
###xml 247 251 <span type="species:ncbi:10090">mice</span>
###xml 317 321 <span type="species:ncbi:10090">mice</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">Mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 575 580 <span type="species:ncbi:10090">Mouse</span>
K-RasV12;Atm-null mice were obtained by crossing transgenic mice carrying a tamoxifen-inducible Cre and a Cre-inducible K-RasV12 endogeneous allele [31] with Atm-null mice [4]. Activation of the Cre-inducible K-RasV12 was performed in 1-month old mice by injection of tamoxifen as previously described [31]. Arf-null mice [50] and p53-null mice [51] were previously described. Mice were housed under standard conditions at the serum-pathogen free facility of the Spanish National Cancer Research Centre (CNIO). Upon signs of morbidity or when required, mice were euthanized. Mouse embryo fibroblasts (MEFs) were obtained from E13.5 embryos as previously described [52] and grown in Dulbecco's Minimum Essential Media (DMEM, Invitrogen, Grand Island, NY, USA) supplemented with 10% FBS (Hyclone, Logan, UT). MEFs were grown in 3% oxygen to minimize premature senescence of Atm-deficient cells. In all experiments with MEFs, low passage (less than 3 passages) MEFs were used.
###end p 51
###begin title 52
Oncogene-induced senescence in MEFs
###end title 52
###begin p 53
###xml 114 121 114 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g001">Fig. 1A</xref>
###xml 137 144 137 144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0005475-g001">Fig. 1C</xref>
###xml 156 163 156 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0005475.s001">Fig. S1</xref>
###xml 197 200 197 200 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 219 222 219 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 226 230 226 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Palmero1">[53]</xref>
###xml 316 320 312 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Matheu1">[54]</xref>
###xml 411 414 407 410 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 440 444 436 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Guerra1">[31]</xref>
###xml 553 557 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-Murga1">[55]</xref>
Cells were retrovirally transduced following standard procedures using constructs based on the vector pBabe-puro (Fig. 1A) or pLPC-puro (Fig. 1C and Suppl. Fig. S1) and expressing oncogenic Ras (H-RasV12) or E1a/IRES/H-RasV12 [53]. Infected cells were selected with 1.5 microg/ml puromycin for 2-3 days as described [54]. Cell extracts were prepared 6 days post-selection. MEFs carrying a tamoxifen-inducible K-RasV12 allele were also used [31]. Quantification of DNA damage by quantitative immunofluorescence of single cells was performed as described [55]. Briefly, cells were grown on muCLEAR-bottom 96-well dishes (Greiner Bio-One) and analyzed on a BD Pathway 855 BioImager (Beckton Dickinson). Image analysis was performed with the AttoVision software (Beckton Dickinson). All the images for quantitative analyses were acquired under nonsaturating exposure conditions.
###end p 53
###begin title 54
Tumor induction and establishment of fibrosarcoma cell lines
###end title 54
###begin p 55
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-GarciaCao1">[43]</xref>
###xml 310 314 310 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0005475-GarciaCao1">[43]</xref>
###xml 154 158 <span type="species:ncbi:381124">corn</span>
###xml 230 235 <span type="species:ncbi:10090">Mouse</span>
For fibrosarcomagenesis, 2-4 mo old animals were injected intramuscularly in one of the rear legs with 1 mg of 3-methyl-cholanthrene (Sigma) dissolved in corn oil, and tumor development was followed, as previously described [43]. Mouse fibrosarcoma cell lines were obtained from tumors as previously described [43]. Briefly, the tumor mass was rinsed in phosphate-buffered saline (PBS) with antibiotics and then minced with razor blades into small pieces that were placed in 100-mm diameter dishes in the presence of DMEM/10% FBS. Cell lines were established from tumor outgrowths after four to six passages. Cells were plated in 3.5-cm diameter plates and, the following day, were irradiated with 10 Gy at 1.94 Gy/min in a Shepherd Mark 1-30 irradiator.
###end p 55
###begin title 56
Metaphase analyses
###end title 56
###begin p 57
Exponentially growing cells were incubated with 0.1 microg/ml colcemide (Gibco, Invitrogen, Paisley, UK) for 2 h at 37degreesC and then fixed in methanol:acetic acid (3:1). Metaphases were spread in acetic acid 45%. Chromosome number, fragments and fusions were analyzed in at least 50 metaphases per cell line.
###end p 57
###begin title 58
Immunoblots and immunohistochemistry
###end title 58
###begin p 59
Whole-cell protein extracts were obtained using RIPA buffer. For immunoblotting, we used the following primary antibodies: anti-p53 (NCL-p53-CM-5p, Novocastra; and 1C12, Cell Signaling Technology), anti-p21 (p21-C-19-G, Santa Cruz Biotechnology), anti-total-Atm (NB100-220, Novus Bio), anti-phospho-Ser1981-Atm (Atmp1981, 200-301-400, Rockland Biochemicals), anti H-Ras (clone 18, BD Biosciences), anti-Arf (Ab80-100, Abcam; and 5-C3-1, Santa Cruz Biotechnology), anti-Chk2 (05-649, clone 7, Upstate), anti-phospho-Chk1 (2341, Cell Signaling Technology), anti-gammaH2AX (05-636, Millipore), and anti-beta-actin (clone AC-15, Sigma). Protein levels were visualized after incubation with the appropriate secondary antibodies conjugated with HRP followed by detection with ECL Plus (Amersham) or conjugated with fluorescein followed by detection with Oddysey (Li Cor Biosiences).
###end p 59
###begin p 60
For immunohistochemistry, formalin-fixed paraffin-embedded tumor samples were incubated with the following antibodies: anti-Ki67 (TEC-3, DAKO), anti-gammaH2AX (clone JBW301, Upstate), anti-Caspase 3 active (R&D Systems), anti-Arf (5-C3-1, Santa Cruz Biotechnology), anti-p53 (NCL-p53-CM-5p, Novocastra), and anti-p21 (p21-C-19-G, Santa Cruz Biotechnology). For quantification, 10 high power fields (40x) were randomly chosen under the microscope and the total number of positive cells was counted for each tumor.
###end p 60
###begin title 61
SA-beta-Galactosidase activity
###end title 61
###begin p 62
SA-beta-Galactosidase activity was evaluated using the "Senescence-betaGal Staining Kit" (Cell Signaling Technology) following the manufacturer's instructions in OCT-embedded lung sections. Stained slides were subsequently stained with nuclear fast red.
###end p 62
###begin title 63
Supporting Information
###end title 63
###begin p 64
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Atm-deficiency does not render MEFs permissive to H-RasV12-driven proliferation A. Primary mouse embryo fibroblasts (MEFs) of the indicated genotypes were retrovirally transduced with H-RasV12 and 2000 cells were seeded in 10-cm diameter plates. After 2 weeks, cells were fixed and stained and colonies were counted. All incubations were done in low oxygen (3%). Top, quantification; bottom, representative plates. B. Same as in A but after retroviral transduction of cells with oncoviral protein E1a and H-RasV12.
###end p 64
###begin p 65
(0.34 MB TIF)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
###xml 88 92 <span type="species:ncbi:10090">mice</span>
###xml 411 416 <span type="species:ncbi:10090">mouse</span>
Expression of K-RasV12 provides a selective advantage for T-lymphomagenesis in Atm-null mice. Left, representative LacZ staining of the thymus 2 days after activation of the K-RasV12 allele by tamoxifen (the oncogenic allele is linked with an IRES to LacZ). Quantification indicates that approximately 8% of the cells are LacZ-positive. Right, representative image of a thymic lymphoma from a K-RasV12;Atm-null mouse. A total of 5 lymphomas were analyzed and all of them were strongly positive for LacZ.
###end p 67
###begin p 68
(0.20 MB TIF)
###end p 68
###begin p 69
Click here for additional data file.
###end p 69
###begin p 70
In vivo senescence in K-RasV12-driven lung adenomas is not affected by the status of Atm. Complete lung sections at low magnification stained with senescence-associated beta-galactosidase (SAbetaGal) and nuclear fast red. Slides were examined blindly by an expert pathologist, Dr. Marta Canamero (CNIO), who determined the grade of the tumors. All the adenomas (grades G1 to G3) were positive for SAbetaGal. The lung in the right side contains an adenocarcinoma that is shown at high magnification below. Adenocarcinomas (grade 4) presented a very weak SAbetaGal staining.
###end p 70
###begin p 71
(0.43 MB TIF)
###end p 71
###begin p 72
Click here for additional data file.
###end p 72
###begin p 73
###xml 148 152 <span type="species:ncbi:10090">Mice</span>
The short-term response of the lung to DNA damage is eliminated in the absence of Atm and it is enhanced in the presence of an extra allele of p53. Mice of the indicated genotypes were irradiated and protein extracts were prepared from their lungs 3 h post-IR. The antibody used for phospho-Ser18-p53 was from Cell Signaling (#9284S).
###end p 73
###begin p 74
(0.12 MB TIF)
###end p 74
###begin p 75
Click here for additional data file.
###end p 75
###begin p 76
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 626 630 <span type="species:ncbi:10090">mice</span>
Arf-deficiency relieves the selective pressure to inactivate p53 in 3MC-fibrosarcomas (nutlin-sensitivity assay). Fibrosarcoma cell lines obtained from the wt or Arf-null mice were treated with 10 microM of the active enantiomer of nutlin (nutlin-3a, N3a) or with the inactive enantiomer (nutlin-3b, N3b). Nutlin activates p53 by inhibiting MDM2. After 48 h, cells were fixed and the proportion of S-phase cells was determined by flow cytometry. All the fibrosarcoma cell lines derived from wt mice did not respond to N3b, thus indicating that p53 was not functional; in contrast, all but one cell lines derived from Arf-null mice responded to N3b by strongly decreasing proliferation.
###end p 76
###begin p 77
(0.07 MB TIF)
###end p 77
###begin p 78
Click here for additional data file.
###end p 78
###begin p 79
###xml 190 197 190 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0005475-t001">Table 1</xref>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
Identification of Atm-null fibrosarcoma cell lines retaining functional p53 (nutlin-sensitivity assay). The large majority of 3MC-fibrosarcomas from Atm-null mice lacked functional p53 (see Table 1), however, two Atm-null cell lines were identified that retained a functional p53. These cell lines, #2 and #3 in the figure, responded to 10 microM nutlin (racemic mixture) by undergoing cell cycle arrest as measured by flow cytometry 48 h after treatment.
###end p 79
###begin p 80
(0.06 MB TIF)
###end p 80
###begin p 81
Click here for additional data file.
###end p 81
###begin p 82
###xml 63 66 63 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ras</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 160 165 <span type="species:ncbi:10090">mouse</span>
We are indebted to Mariano Barbacid for his kind gift of the K-RasV12 mice, to Marta Canamero for the pathological analyses, and to Maribel Munoz for excellent mouse colony management.
###end p 82
###begin title 83
References
###end title 83
###begin article-title 84
Ataxia-telangiectasia and related diseases.
###end article-title 84
###begin article-title 85
The ATM gene and ataxia telangiectasia.
###end article-title 85
###begin article-title 86
Targeted disruption of ATM leads to growth retardation, chromosomal fragmentation during meiosis, immune defects, and thymic lymphoma.
###end article-title 86
###begin article-title 87
###xml 14 18 <span type="species:ncbi:10090">mice</span>
Atm-deficient mice: a paradigm of ataxia telangiectasia.
###end article-title 87
###begin article-title 88
###xml 63 67 <span type="species:ncbi:10090">mice</span>
Pleiotropic defects in ataxia-telangiectasia protein-deficient mice.
###end article-title 88
###begin article-title 89
Atm heterozygosity cooperates with loss of Brca1 to increase the severity of mammary gland cancer and reduce ductal branching.
###end article-title 89
###begin article-title 90
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Atm heterozygous deficiency enhances development of mammary carcinomas in p53 heterozygous knockout mice.
###end article-title 90
###begin article-title 91
Atm-haploinsufficiency enhances susceptibility to carcinogen-induced mammary tumors.
###end article-title 91
###begin article-title 92
ATM promotes apoptosis and suppresses tumorigenesis in response to Myc.
###end article-title 92
###begin article-title 93
Atm deficiency affects both apoptosis and proliferation to augment Myc-induced lymphomagenesis.
###end article-title 93
###begin article-title 94
The Myc-evoked DNA damage response accounts for treatment resistance in primary lymphomas in vivo.
###end article-title 94
###begin article-title 95
Atm is a negative regulator of intestinal neoplasia.
###end article-title 95
###begin article-title 96
ATM and p21 cooperate to suppress aneuploidy and subsequent tumor development.
###end article-title 96
###begin article-title 97
The DNA damage response: ten years after.
###end article-title 97
###begin article-title 98
###xml 55 60 <span type="species:ncbi:9606">human</span>
The role of double-strand break repair - insights from human genetics.
###end article-title 98
###begin article-title 99
DNA repair, genome stability, and aging.
###end article-title 99
###begin article-title 100
DNA damage signalling guards against activated oncogenes and tumour progression.
###end article-title 100
###begin article-title 101
An oncogene-induced DNA damage model for cancer development.
###end article-title 101
###begin article-title 102
###xml 64 69 <span type="species:ncbi:9606">human</span>
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.
###end article-title 102
###begin article-title 103
###xml 67 72 <span type="species:ncbi:9606">human</span>
Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions.
###end article-title 103
###begin article-title 104
Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints.
###end article-title 104
###begin article-title 105
Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication.
###end article-title 105
###begin article-title 106
The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence.
###end article-title 106
###begin article-title 107
p53: guardian of the genome and policeman of the oncogenes.
###end article-title 107
###begin article-title 108
Cellular senescence: hot or what?
###end article-title 108
###begin article-title 109
p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.
###end article-title 109
###begin article-title 110
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.
###end article-title 110
###begin article-title 111
Tumour biology: Policing of oncogene activity by p53.
###end article-title 111
###begin article-title 112
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis.
###end article-title 112
###begin article-title 113
Id1 cooperates with oncogenic Ras to induce metastatic mammary carcinoma by subversion of the cellular senescence response.
###end article-title 113
###begin article-title 114
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context.
###end article-title 114
###begin article-title 115
###xml 106 110 <span type="species:ncbi:10090">mice</span>
Loss of p21 increases sensitivity to ionizing radiation and delays the onset of lymphoma in atm-deficient mice.
###end article-title 115
###begin article-title 116
Regulation of reactive oxygen species by Atm is essential for proper response to DNA double-strand breaks in lymphocytes.
###end article-title 116
###begin article-title 117
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 17 22 <span type="species:ncbi:9606">human</span>
Mouse models for human lung cancer.
###end article-title 117
###begin article-title 118
###xml 75 79 <span type="species:ncbi:10090">mice</span>
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.
###end article-title 118
###begin article-title 119
###xml 59 65 <span type="species:ncbi:10090">murine</span>
The differential effects of mutant p53 alleles on advanced murine lung cancer.
###end article-title 119
###begin article-title 120
Tumour biology: senescence in premalignant tumours.
###end article-title 120
###begin article-title 121
###xml 38 43 <span type="species:ncbi:9606">human</span>
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
###end article-title 121
###begin article-title 122
Frequent activation of c-kis as a transforming gene in fibrosarcomas induced by methylcholanthrene.
###end article-title 122
###begin article-title 123
###xml 116 122 <span type="species:ncbi:10090">murine</span>
Activation of ras oncogenes and expression of tumor-specific transplantation antigens in methylcholanthrene-induced murine fibrosarcomas.
###end article-title 123
###begin article-title 124
###xml 73 78 <span type="species:ncbi:10090">mouse</span>
Analysis of the c-myc, K-ras and p53 genes in methylcholanthrene-induced mouse sarcomas.
###end article-title 124
###begin article-title 125
###xml 92 97 <span type="species:ncbi:10090">mouse</span>
p53 gene mutation and loss of heterozygosity of chromosome 11 in methylcholanthrene-induced mouse sarcomas.
###end article-title 125
###begin article-title 126
###xml 12 16 <span type="species:ncbi:10090">mice</span>
"Super p53" mice exhibit enhanced DNA damage response, are tumor resistant and age normally.
###end article-title 126
###begin article-title 127
###xml 74 79 <span type="species:ncbi:10090">mouse</span>
Induction of p53-dependent senescence by the MDM2 antagonist nutlin-3a in mouse cells of fibroblast origin.
###end article-title 127
###begin article-title 128
Bmi1 is critical for lung tumorigenesis and bronchioalveolar stem cell expansion.
###end article-title 128
###begin article-title 129
Atm is dispensable for p53 apoptosis and tumor suppression triggered by cell cycle dysfunction.
###end article-title 129
###begin article-title 130
Tumor suppression by p53 in the absence of Atm.
###end article-title 130
###begin article-title 131
Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis.
###end article-title 131
###begin article-title 132
INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53.
###end article-title 132
###begin article-title 133
###xml 25 30 <span type="species:ncbi:10090">mouse</span>
Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF.
###end article-title 133
###begin article-title 134
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Tumor spectrum analysis in p53-mutant mice.
###end article-title 134
###begin article-title 135
###xml 0 6 <span type="species:ncbi:10090">Murine</span>
Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.
###end article-title 135
###begin article-title 136
Induction of senescence by oncogenic Ras.
###end article-title 136
###begin article-title 137
Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.
###end article-title 137
###begin article-title 138
Global chromatin compaction limits the strength of the DNA damage response.
###end article-title 138
###begin p 139
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 139
###begin p 140
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: M.M. and M.C. are supported by a Ramon y Cajal contract from the Spanish Ministry of Science (MICINN) and by a grant from Fondo de Investigaciones Sanitarias to M.M. (PI05945). A.O.-M. is supported by a predoctoral contract from the Government of Madrid. Work in O.F.-C.A'A's laboratory is supported by the CNIO, Caja Madrid Foundation, the MICINN (RYC-2003-002731, CSD2007-00017 and BFU2005-09429), the Epigenome Network of Excellence (EU-FP6) and the European Research Council. Work at the laboratory of M.S. is funded by the CNIO, the MICINN (SAF2005-03018 and OncoBIO-CONSOLIDER), the Government of Madrid (GsSTEM), the European Union (PROTEOMAGE), the Marcelino Botin Foundation, and the European Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 140

